Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Watson Pharmaceuticals Inc-Deals & Alliances Report | Mar 2011 | £380 | 100% |
| Watson Pharmaceuticals Inc-Detailed Product Pipeline | Mar 2011 | £475 | 97% |
| Watson Pharmavitae Generics Profile |
Sep 2007 | £2,400 | 88% |
| Savient Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare Deals and Alliances Profile |
Jul 2009 | £160 | 84% |
| Paladin Labs Inc. – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 83% |
| Narcolepsy Therapeutics | Jul 2010 | £2,180 | 78% |
| Columbia Laboratories Inc. – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 77% |
| Biosimilars Approval Pathways in the US and Europe Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment |
Apr 2011 | £2,215 | 77% |
| Men's Health Therapeutics Market to 2016 Selective Serotonin Reuptake Inhibitors, Hormone Replacement Therapy and Phosphodiesterase Type-5 Inhibitors Will Dominate the Market |
Aug 2010 | £2,215 | 77% |
| Testosterone Replacement Therapy (TRT) | Apr 2011 | £2,910 | 77% |
| Mylan Inc. – Product Pipeline Review H2 2011 |
Nov 2011 | £315 | 76% |
| Infertility - Pipeline Review H2 2011 |
Sep 2011 | £315 | 74% |
| Contraceptives | Oct 2010 | £2,845 | 73% |
| Inflammatory Bowel Disease Therapeutics | Apr 2010 | £2,500 | 70% |
| The Future of Biosimilars Market Forecasts to 2015 |
Dec 2009 | £2,215 | 70% |
| Guide to US Specialty Pharmaceutical Market | Jan 2011 | £1,135 | 68% |
| Cancer Therapies Global Market Opportunities |
Nov 2009 | £1,895 | 68% |
| Drug Delivery Systems US Market Outlook, Advances for Pharma, Biotech & Medical Devices |
Sep 2006 | £1,450 | 68% |
| Biosimilars | Feb 2011 | £2,845 | 67% |
| Alzheimer's Disease Therapeutics and Diagnostics Global Markets |
Jan 2010 | £3,065 | 64% |
| Antibiotics Global Trends |
Nov 2009 | £1,895 | 64% |
| Anemia Drugs | Apr 2010 | £2,500 | 64% |
| Antibacterial Drugs | Apr 2010 | £2,500 | 63% |
| Benign Prostatic Hyperplasia - Pipeline Review H2 2011 |
Sep 2011 | £315 | 62% |
| Renal Disease Treatments: Products and Therapies | Nov 2009 | £3,065 | 60% |
| Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015 |
Jan 2011 | £995 | 60% |
| Anti-Hypertensive Drugs | Feb 2010 | £2,500 | 59% |
| Cardiovascular Drugs | Apr 2010 | £2,815 | 59% |
| Pharmaceutical Contract Manufacturing | Jan 2011 | £2,845 | 59% |
| Global Biosimilars Industry | Aug 2011 | £380 | 58% |
